HNB
TBPH

Huntington National Bank’s Theravance Biopharma TBPH Stock Holding History

Huntington National Bank’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88K Hold
228
– – ﹤0.01% 2310
2026
Q1 		$3.7K Hold
228
– – ﹤0.01% 2139
2025
Q4 		$4.27K Hold
228
– – ﹤0.01% 2047
2025
Q3 		$3.33K Hold
228
– – ﹤0.01% 2103
2025
Q2 		$2.52K Buy
228
+178
+356% +$1.73K ﹤0.01% 2161
2025
Q1 		$447 Hold
50
– – ﹤0.01% 2486
2024
Q4 		$471 Sell
50
-88
-64% -$801 ﹤0.01% 2511
2024
Q3 		$1.11K Buy
138
+50
+57% +$433 ﹤0.01% 2363
2024
Q2 		$746 Hold
88
– – ﹤0.01% 2361
2024
Q1 		$789 Buy
+88
New +$815 ﹤0.01% 2315

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Huntington National Bank's TBPH Position: Q2 2026 in Review

Huntington National Bank held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 228 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2310.

Huntington National Bank first reported a position in TBPH in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.27K in Q4 2025. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Huntington National Bank held 228 shares of Theravance Biopharma worth $3.88K as of Q2 2026.
  • Huntington National Bank left its Theravance Biopharma share count unchanged in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2310 holding.
  • Huntington National Bank first reported a position in Theravance Biopharma in Q1 2024 and has held it in 10 quarters since.
  • Huntington National Bank's Theravance Biopharma position peaked at $4.27K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.